Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 179 - Healthcare Infection Control Practices Advisory Committee - Authorized by Law


Committee NameHealthcare Infection Control Practices Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number179
Original Establishment Date1/19/1991Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*46
Current Charter Date1/19/2021Designated Fed Officer Position Title*Deputy Director, DHQP
Date Of Renewal Charter1/19/2023Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Michael
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Bell
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixM.D.
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*404-639-6490
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(404) 639-3039
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*Scientific Technical Program Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee accomplishes its purpose by: 1) informing the development of CDC evidence-based guidelines for the prevention of healthcare-associated infections; 2) providing infection prevention and control guidance to address new or changing infectious disease threats such as pandemic influenza, severe acute respiratory syndrome coronavirus 2, or antimicrobial (antibiotic) resistant pathogens; and 3) providing input on national surveillance efforts. During fiscal year 2022, the committee continued to provide input into the draft CDC guidelines: the Guideline for Infection Control in Healthcare Personnel, and the Guideline for Infection Prevention in Neonatal Intensive Care Unit Patients. The committee also provided input on considerations for use of enhanced barrier precautions in nursing facilities as well as input on improving neonatal and pediatric surveillance definitions for the National Healthcare Safety Network, which is the Nation’s mostly widely used healthcare-associated infection tracking system. The committee also formed a new workgroup, the Isolation Precautions Guideline Workgroup, which will begin the task of updating the “Guidelines for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007).”
How is membership balanced?*The committee consists of 14 public members. In addition to considerations of balanced racial and ethnic groups, gender, and geographic representation, to be effective the committee must also be balanced by depth of experience (e.g., newer to the field vs. senior-level) and perspective (e.g., national, state, local). Furthermore, the committee must maintain a balance of expertise that is dependent upon the planned work of the committee. The committee’s membership represents expertise including, but not limited to, infectious diseases, infection prevention, healthcare epidemiology, nursing, clinical and environmental microbiology, surgery, hospitalist medicine, internal medicine, epidemiology, health policy, health services research, public health, and related fields.
How frequent & relevant are cmte mtgs?*Historically, the committee has met in-person, but in fiscal year 2022 the committee met four times via video/tele-conference due to the COVID-19 pandemic. Continued operation of the committee in fiscal year 2022 and beyond is required for the ongoing development, dissemination, and evaluation of CDC's infection control guidelines to prevent healthcare-associated infections and related adverse events, prevent the emergence of antimicrobial-resistant microorganisms, and improve quality of care across the spectrum of healthcare delivery, including nursing home care. The committee provides critical guidance to CDC regarding these issues and as needed provides input on related issues such as surveillance and healthcare infection control practices for novel and emerging infectious diseases (e.g. Avian influenza, MERS, SARS, H1N1, SARS-CoV-2).
Why advice can't be obtained elsewhere?*CDC plays a unique role in healthcare-associated infection prevention activities in the U.S. and worldwide by developing and disseminating evidence-based infection control guidelines for preventing healthcare-associated infections and other adverse events in healthcare settings that are used to guide healthcare facilities in developing local protocols and procedures for infection control. Some recommendations become the standard for infection control when incorporated into other Agency and organizations standards (e.g., facility inspectors/surveyors such as those by Accreditation organizations or the Centers for Medicare and Medicaid Services). CDC actively investigates with State Health Departments and derives new evidence from outbreaks of healthcare-associated infections and CDC collaborates with other federal agencies and academic partners to apply those findings to update and improve prevention guidelines. CDC also manages and leads the National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infection (HAI) tracking system. NHSN provides facilities, states, regions, and the nation with data from over 25,000 medical facilities to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections. CDC uses input and advice from recognized experts described above to optimize guidelines and recommendations, assess trends, inform ongoing improvements to HAI monitoring and tracking, and review policy implications relevant to prevention of healthcare-associated infections.
Why close or partially close meetings?N/A
Recommendation RemarksNicholas Daniels, Michael Lin, and Lisa Maragakis were extended through 12/30/22
Michael Anne Preas retired in 6/30/2022; Deverick Anderson, Elaine Dekker, and Hilary Babcock were retired in 12/30/2021; Brooke Decker was a new ex officio member for NIH replacing Tara Palmore. Brooke started 4/20/2022 and rolled off of the committee August 23, 2022.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentHealthcare associated infections cost the United States tens of millions of dollars annually. Implementation and adherence to CDC infection control guidelines that were informed from input from HICPAC potentially represent substantial cost savings for the nation and improved patient safety by reducing morbidity and mortality.Grants Review CommentThis committee does not engage in grant review.
Number Of Recommendations*518Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe six recommendations provided in FY2021 have been finalized. There were no additional recommendations made for FY2022. In addition, the committee had numerous discussions in FY2022 that informed the national pandemic response, and healthcare infection control recommendations that were needed.Access Agency WebsiteYes
% of Recs Fully Implemented*90.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentRecommendations to the agency have been implemented and are reflected in CDC guidelines and possible CDC Guideline recommendation updates.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentSometimes recommendations from the Committee are one of several internal and external inputs that CDC might use to inform decisions (e.g., federal register public comment period, other federal agency review, etc). Also, some recommendations will not be implemented until CDC Guidelines are published. CDC is currently working to refine, finalize, and publish the surveillance methods and guidelines that are informed by Committee's input.Access OtherYes
Agency Feedback*YesAccess CommentPublic Meetings
Agency Feedback Comment*The agency provides feedback to the committee through updates at regularly scheduled meetings and email communication to notify the HICPAC when action has been taken based on their recommendations.Narrative Description*CDC's mission is to protect America from health safety and security threats and to increase quality of life by preventing and controlling disease, injury, and disability. The agency accomplishes its mission by working with partners to monitor health, develop and advocate sound public health policies, and implement prevention strategies. The Healthcare Infection Control Practices Advisory Committee supports CDC's mission by providing input into CDC's guidelines and recommendations for prevention of healthcare-associated infections (HAIs) and antimicrobial resistance. HICPAC also supports the CDC mission by providing strategy for surveillance as well as monitoring and tracking HAIs to improve patient safety in U.S. healthcare facilities.
Hide Section - COSTS


Payments to Non-Federal Members*$9,000.00Est Payments to Non-Fed Members Next FY*$38,750.00
Payments to Federal Members*$13,517.00Est. Payments to Fed Members Next FY*$52,040.00
Payments to Federal Staff*$52,776.00Estimated Payments to Federal Staff*$34,874.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$34,483.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$300,845.00Est. Other Costs Next FY*$310,385.00
Total Costs$376,138.00Est. Total Next FY*$470,532.00
Date Cost Last Modified11/3/2022 11:44 AMEst. Fed Staff Support Next FY*0.21
Federal Staff Support (FTE)*0.36Est Cost Remarks
Cost RemarksTo comply with §2(b)(5) of the FACA, the Federal Management Regulation (FMR Bulletin 2022-F1) requires agencies report all costs of committee activities, including FRN notices for the operation of a committee.  
Hide Section - Interest Areas

Interest Areas

Basic Science
Food and Drugs
Medical Devices
Health Care
Medical Education
Medical Practitioners
Public Health
Occupational Safety and Health
Health and Health Research
Medicine and Dentistry


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-040268Healthcare Infection Control Practices Advisory Committee2021
 COM-038543Healthcare Infection Control Practices Advisory Committee2020
 COM-036415Healthcare Infection Control Practices Advisory Committee2019
 COM-034619Healthcare Infection Control Practices Advisory Committee2018
 COM-001889Healthcare Infection Control Practices Advisory Committee2017
 COM-002276Healthcare Infection Control Practices Advisory Committee2016
 COM-004088Healthcare Infection Control Practices Advisory Committee2015
 COM-004373Healthcare Infection Control Practices Advisory Committee2014
 COM-005835Healthcare Infection Control Practices Advisory Committee2013
 COM-006643Healthcare Infection Control Practices Advisory Committee2012
 COM-008077Healthcare Infection Control Practices Advisory Committee2011
 COM-009123Healthcare Infection Control Practices Advisory Committee2010
 COM-010241Healthcare Infection Control Practices Advisory Committee2009
 COM-010767Healthcare Infection Control Practices Advisory Committee2008
 COM-011917Healthcare Infection Control Practices Advisory Committee2007
 COM-012912Healthcare Infection Control Practices Advisory Committee2006
 COM-014070Healthcare Infection Control Practices Advisory Committee2005
 COM-014447Healthcare Infection Control Practices Advisory Committee2004
 COM-015837Healthcare Infection Control Practices Advisory Committee2003
 COM-016615Healthcare Infection Control Practices Advisory Committee2002
 COM-017603Healthcare Infection Control Practices Advisory Committee2001
 COM-018518Healthcare Infection Control Practices Advisory Committee2000
 COM-019604Healthcare Infection Control Practices Advisory Committee1999
 COM-020372Hospital Infection Control Practices Advisory Committee1998
 COM-021787Hospital Infection Control Practices Advisory Committee1997